Trial Profile
Phase 1 Dose-Escalation and Pharmacokinetic Study of TG02 Citrate in Patients With Advanced Hematological Malignancies
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Zotiraciclib (Primary) ; Carfilzomib; Dexamethasone
- Indications Acute myeloid leukaemia; Chronic myeloid leukaemia; Multiple myeloma; Myelodysplastic syndromes; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- Sponsors Adastra Pharmaceuticals; Tragara Pharmaceuticals
- 05 May 2016 Status changed from recruiting to completed.
- 12 Nov 2015 According to a Tragara Pharmaceuticals media release, clinical proof-of-concept has been achieved in this study,
- 05 Nov 2015 Planned End Date changed from 1 May 2016 to 1 Aug 2016 as reported by ClinicalTrials.gov record.